We are delighted to announce that SinoMedCare BioTech Co., Ltd. (SMC) has become the exclusive distributor of our vibrating mesh nebulizer Pulmogine in China.
HCmed Innovations is pleased to inform that it has received NMPA approval from the National Medical Products Administration in China for its handheld mesh nebulizer, Pulmogine.
Aiming to continue expanding its global presence and promoting its new brand “Pulmogine,” HCmed Innovations participated at two main events held in China this month.
HCmed Innovations Co., Ltd., in collaboration with one of the world's top 10 pharmaceutical companies, has officially launched its vibrating mesh nebulizer, Deepro, in the Federative Republic of Brazil.
HCmed Innovations (HCmed) confirmed on December 27, 2017, that Vivo capital, through the fund under its management, PANDA Fund, L.P., has become its strategic investor.